Article

Revised Evidence-based Pharmacotherapy Textbook Now Available-September 2008

The new edition of Pharmacotherapy: A Pathophysiologic Approach is a recommended reference book for pharmacists.

The seventh edition of Pharmacotherapy: A Pathophysiologic Approach (Joseph T. DiPiro, PharmD, FCCP; Robert L. Talpert, PharmD, FCCP, BCPS; Gary C. Yee, PharmD, FCCP; Gary R. Matzke, FCP, FCCP; Barbara G. Wells, PharmD, FASHP, FCCP, BCPP; L. Michael Posey, BSPharm) is now available.

This textbook sets the standard in therapeutics courses in North American schools of pharmacy and a trusted reference for those in practice. It not only offers evidence-based approaches to the medication treatment of diseases, but it goes beyond drug indications and dosages to include the initial selection, proper administration, and monitoring of drugs.

This new revision features expanded evidence-based recommendations and extended coverage of the timely issue of palliative care and pain medicine. Other new additions also include Web-based chapters and new chapters on drug therapy individualization; patients with hepatic disease; primary pulmonary hypertension; management of the developmentally disabled; substance abuse; drug therapy of influenza; and psychosomatic medicine.

Pedagogic features include:

• “Key concepts” highlighted in each chapter

• “Clinical Presentation” boxes summarize the most common disease signs and symptoms covered in each chapter

• “Clinical Controversies” boxes are presented in the treatment sections of the disease-oriented chapters and examine the complicated issues faced by students and clinicians in providing drug therapy

• Clear therapeutic recommendations in each disease-specific chapter

• “Evaluation of Therapeutic Outcomes” boxes in each disease-specific chapter, containing key monitoring guidelines that facilitate the development of a pharmaceutical, nursing, or medical care plan

Related Videos
Jonathan Meyer, MD: Cognitive Gains, Dopamine-Free Schizophrenia Treatment with Xanomeline Trospium Chloride
Chelsie Monroe: Challenges Clinicians Should Consider When Prescribing Muscarinic Modulators for Schizophrenia
Allysa Saggese, NP | Credit: Weill Cornell Medicine
Zobair Younossi, MD, MPH | Credit: American College of Gastroenterology
Thumbnail for schizophrenia special report around approval of Cobenfy.
Thumbnail for schizophrenia special report around approval of Cobenfy.
Thumbnail for schizophrenia special report around approval of Cobenfy.
Thumbnail for schizophrenia special report around approval of Cobenfy.
Thumbnail for schizophrenia special report around approval of Cobenfy.
© 2024 MJH Life Sciences

All rights reserved.